FR2730637B1
(fr)
|
1995-02-17 |
1997-03-28 |
Rhone Poulenc Rorer Sa |
Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
|
US7422902B1
(en)
|
1995-06-07 |
2008-09-09 |
The University Of British Columbia |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
DE69634084T2
(de)
*
|
1995-06-07 |
2005-12-08 |
Inex Pharmaceuticals Corp. |
Herstellung von lipid-nukleinsäure partikeln duch ein hydrophobische lipid-nukleinsäuree komplexe zwischenprodukt und zur verwendung in der gentransfer
|
FR2739292B1
(fr)
*
|
1995-09-28 |
1997-10-31 |
Rhone Poulenc Rorer Sa |
Composition pharmaceutique utile pour la transfection d'acides nucleiques et ses utilisations
|
GB2324534B
(en)
*
|
1996-01-06 |
2000-05-10 |
Danbiosyst Uk |
Composition for delivery of nucleic acid to a cell
|
EP0934082B1
(de)
*
|
1996-10-23 |
2002-07-17 |
SKW Trostberg Aktiengesellschaft |
Verfahren zur herstellung von biologisch aktiven polymernanopartikel-nucleinsäure-konjugaten
|
PT956001E
(pt)
*
|
1996-11-12 |
2012-12-06 |
Univ California |
Preparação de formulações estáveis de complexos do tipo lípido-ácido nucleico para uma entrega eficiente in vivo
|
US6884430B1
(en)
*
|
1997-02-10 |
2005-04-26 |
Aventis Pharma S.A. |
Formulation of stabilized cationic transfection agent(s) /nucleic acid particles
|
US6489458B2
(en)
|
1997-03-11 |
2002-12-03 |
Regents Of The University Of Minnesota |
DNA-based transposon system for the introduction of nucleic acid into DNA of a cell
|
US5912225A
(en)
|
1997-04-14 |
1999-06-15 |
Johns Hopkins Univ. School Of Medicine |
Biodegradable poly (phosphoester-co-desaminotyrosyl L-tyrosine ester) compounds, compositions, articles and methods for making and using the same
|
US6524613B1
(en)
|
1997-04-30 |
2003-02-25 |
Regents Of The University Of Minnesota |
Hepatocellular chimeraplasty
|
DE19726186A1
(de)
*
|
1997-06-20 |
1998-12-24 |
Boehringer Ingelheim Int |
Komplexe für den Transport von Nukleinsäure in höhere eukaryotische Zellen
|
US20020022034A1
(en)
*
|
1997-09-15 |
2002-02-21 |
Julianna Lisziewicz |
Therapeutic DNA vaccination
|
NZ503334A
(en)
|
1997-09-15 |
2002-05-31 |
Genetic Immunity Llc |
A gene delivering complex having a vector with a specific affinity for a foreign genetic material and a second site having a specific affinity for a receptor on an antigen presenting cell
|
DE19743135A1
(de)
*
|
1997-09-30 |
1999-04-01 |
Hoechst Marion Roussel De Gmbh |
Biologisch verträgliche niedermolekular Polyethylenimine
|
EP1096957A1
(en)
*
|
1998-06-18 |
2001-05-09 |
Johns Hopkins University School of Medicine |
Methods and reagents for intramuscular delivery of nucleic acids
|
US6916490B1
(en)
|
1998-07-23 |
2005-07-12 |
UAB Research Center |
Controlled release of bioactive substances
|
US6562371B1
(en)
*
|
1998-11-02 |
2003-05-13 |
Terumo Kabushiki Kaisha |
Liposomes
|
US7160682B2
(en)
*
|
1998-11-13 |
2007-01-09 |
Regents Of The University Of Minnesota |
Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell
|
CN1354678A
(zh)
*
|
1999-04-02 |
2002-06-19 |
研究发展基金会 |
用于气溶胶传递的聚乙烯亚胺:dna制剂
|
US6770740B1
(en)
|
1999-07-13 |
2004-08-03 |
The Regents Of The University Of Michigan |
Crosslinked DNA condensate compositions and gene delivery methods
|
FR2797402B1
(fr)
|
1999-07-15 |
2004-03-12 |
Biomerieux Stelhys |
Utilisation d'un polypeptide pour detecter, prevenir ou traiter un etat pathologique associe a une maladie degenerative, neurologique ou autoimmune
|
DE19960206A1
(de)
*
|
1999-12-14 |
2001-07-19 |
Frank Czubayko |
Komplexierung von RNS mit Polyethyleniminen zur deren Stabilisierung und zellulären Einschleusung
|
CA2363180A1
(en)
|
1999-12-28 |
2001-07-05 |
Transgene S.A. |
Use of lithium (li+) for the preparation of a composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy
|
CN1433478A
(zh)
*
|
1999-12-30 |
2003-07-30 |
诺瓦提斯公司 |
用于基因治疗的新的胶体合成载体
|
FR2805271B1
(fr)
*
|
2000-02-18 |
2002-04-26 |
Aventis Pharma Sa |
Procede de preparation de polyalkylenimines fonctionnalises, compositions les contenant et leurs utilisations
|
FR2813605B1
(fr)
*
|
2000-09-05 |
2002-10-18 |
Aventis Pharma Sa |
Composes acidosensibles, leur preparation et utilisations
|
CN1452617A
(zh)
*
|
2000-09-05 |
2003-10-29 |
甘瑟尔股份有限公司 |
酸敏感化合物、其制备方法和用途
|
FR2814370B1
(fr)
*
|
2000-09-22 |
2004-08-20 |
Centre Nat Rech Scient |
Utilisation d'un complexe acide nucleique/pei pour le ciblage de cellules souches du cerveau
|
EP1326645A1
(de)
*
|
2000-10-09 |
2003-07-16 |
Bayer Aktiengesellschaft |
Komplexe zur einführung von nukleinsäuren in zellen
|
DE10145134A1
(de)
*
|
2000-10-09 |
2002-05-16 |
Bayer Ag |
Komplexe zur Einführung von Nukleinsäuren in Zellen
|
US20020091242A1
(en)
|
2000-10-11 |
2002-07-11 |
Michel Bessodes |
Acid-sensitive compounds, their preparation and uses
|
JP2004537501A
(ja)
*
|
2001-02-01 |
2004-12-16 |
ボード オブ リージェンツ, ザ ユニバーシティ オブ テキサス システム |
肺への遺伝子送達のための安定化ポリマーエアロゾル
|
US6652886B2
(en)
|
2001-02-16 |
2003-11-25 |
Expression Genetics |
Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
|
WO2002100435A1
(en)
*
|
2001-06-11 |
2002-12-19 |
Centre Hospitalier Universitaire De Montreal |
Compositions and methods for enhancing nucleic acid transfer into cells
|
EP1450856B1
(en)
|
2001-09-14 |
2009-11-11 |
Cytos Biotechnology AG |
Packaging of immunostimulatory cpg into virus-like particles: method of preparation and use
|
AU2002348163A1
(en)
*
|
2001-11-02 |
2003-05-19 |
Intradigm Corporation |
Therapeutic methods for nucleic acid delivery vehicles
|
SI1479985T1
(sl)
|
2002-01-17 |
2017-10-30 |
Alfa Laval Corporate Ab |
Potopni uparjalnik, ki vsebuje ploščni toplotni izmenjevalnik in cilindrično ohišje, kjer je nameščen ploščni toplotni izmenjevalnik
|
WO2003089618A2
(en)
*
|
2002-04-22 |
2003-10-30 |
Regents Of The University Of Minnesota |
Transposon system and methods of use
|
DE60328383D1
(de)
|
2002-05-24 |
2009-08-27 |
Mirus Bio Corp |
Zusammensetzungen zur zuführung von nukleinsäuren an zellen
|
DE60334618D1
(de)
|
2002-06-28 |
2010-12-02 |
Protiva Biotherapeutics Inc |
Verfahren und vorrichtung zur herstellung von liposomen
|
KR101360955B1
(ko)
*
|
2002-09-13 |
2014-02-10 |
레플리코르 인코포레이티드 |
비서열 상보적 항바이러스 올리고뉴클레오티드
|
US20050196382A1
(en)
*
|
2002-09-13 |
2005-09-08 |
Replicor, Inc. |
Antiviral oligonucleotides targeting viral families
|
EP1413874A1
(en)
|
2002-10-16 |
2004-04-28 |
Streck Laboratories, Inc. |
Method and device for collecting and preserving cells for analysis
|
US7153905B2
(en)
*
|
2003-03-21 |
2006-12-26 |
The General Hospital Corporation |
Hyperbranched dendron and methods of synthesis and use thereof
|
SG190613A1
(en)
|
2003-07-16 |
2013-06-28 |
Protiva Biotherapeutics Inc |
Lipid encapsulated interfering rna
|
JP4842821B2
(ja)
|
2003-09-15 |
2011-12-21 |
プロチバ バイオセラピューティクス インコーポレイティッド |
ポリエチレングリコール修飾脂質化合物およびその使用
|
CA2558262A1
(en)
*
|
2004-03-01 |
2005-09-15 |
Massachusetts Institute Of Technology |
Rnai-based therapeutics for allergic rhinitis and asthma
|
US20050215507A1
(en)
*
|
2004-03-04 |
2005-09-29 |
Massachusetts Institute Of Technology |
Therapeutic anti-cancer DNA
|
US20060026699A1
(en)
*
|
2004-06-04 |
2006-02-02 |
Largaespada David A |
Methods and compositions for identification of genomic sequences
|
EP1766035B1
(en)
|
2004-06-07 |
2011-12-07 |
Protiva Biotherapeutics Inc. |
Lipid encapsulated interfering rna
|
JP4764426B2
(ja)
|
2004-06-07 |
2011-09-07 |
プロチバ バイオセラピューティクス インコーポレイティッド |
カチオン性脂質および使用方法
|
EP1773857A4
(en)
|
2004-07-02 |
2009-05-13 |
Protiva Biotherapeutics Inc |
THE IMMUNE SYSTEM STIMULATING SIRNA MOLECULES AND APPLICATIONS THEREOF
|
AU2006308765B2
(en)
|
2005-11-02 |
2013-09-05 |
Arbutus Biopharma Corporation |
Modified siRNA molecules and uses thereof
|
US7915399B2
(en)
|
2006-06-09 |
2011-03-29 |
Protiva Biotherapeutics, Inc. |
Modified siRNA molecules and uses thereof
|
US20080312174A1
(en)
*
|
2007-06-05 |
2008-12-18 |
Nitto Denko Corporation |
Water soluble crosslinked polymers
|
JP2010539245A
(ja)
*
|
2007-09-14 |
2010-12-16 |
日東電工株式会社 |
薬物担体
|
EP2047858A1
(en)
|
2007-10-10 |
2009-04-15 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Combination products for treating cancer
|
DE102008016275A1
(de)
|
2008-03-28 |
2009-11-19 |
Biontex Laboratories Gmbh |
Verbesserung von Transfektionsergebnissen nicht-viraler Genliefersysteme durch Blockierung des angeborenen Immunsystems
|
WO2009065618A2
(de)
|
2007-11-22 |
2009-05-28 |
Biontex Laboratories Gmbh |
Verbesserung von transfektionsergebnissen nicht-viraler genliefersysteme durch beeinflussung des angeborenen immunsystems
|
DE102008023913A1
(de)
|
2008-05-16 |
2009-11-19 |
Biontex Laboratories Gmbh |
Verbesserung von Transfektionsergebnissen nicht-viraler Genliefersysteme durch Beeinflussung des angeborenen Immunsystems
|
DE102007056488A1
(de)
|
2007-11-22 |
2009-07-23 |
Biontex Laboratories Gmbh |
Steigerung von Transfektionseffizienzen nicht-viraler Genliefersysteme durch Blockierung des angeborenen Immunsystems
|
GB0724253D0
(en)
|
2007-12-12 |
2008-01-30 |
Fermentas Uab |
Transfection reagent
|
AU2008342535B2
(en)
|
2007-12-27 |
2015-02-05 |
Arbutus Biopharma Corporation |
Silencing of polo-like kinase expression using interfering RNA
|
US7687027B2
(en)
*
|
2008-02-27 |
2010-03-30 |
Becton, Dickinson And Company |
Cleaning compositions, methods and materials for reducing nucleic acid contamination
|
FR2928373B1
(fr)
*
|
2008-03-05 |
2010-12-31 |
Centre Nat Rech Scient |
Polymere derive de la polyethylenimine lineaire pour le transfert de gene.
|
CA2721333C
(en)
|
2008-04-15 |
2020-12-01 |
Protiva Biotherapeutics, Inc. |
Novel lipid formulations for nucleic acid delivery
|
CA2721380A1
(en)
|
2008-04-15 |
2009-10-22 |
Protiva Biotherapeutics, Inc. |
Silencing of csn5 gene expression using interfering rna
|
CA2722835C
(en)
*
|
2008-05-15 |
2018-11-27 |
National Research Council Of Canada |
Process, vectors and engineered cell lines for enhanced large-scale transfection
|
AU2009303345B2
(en)
|
2008-10-09 |
2015-08-20 |
Arbutus Biopharma Corporation |
Improved amino lipids and methods for the delivery of nucleic acids
|
US20100167271A1
(en)
*
|
2008-12-30 |
2010-07-01 |
Streck, Inc. |
Method for screening blood using a preservative that may be in a substantially solid state form
|
US11634747B2
(en)
*
|
2009-01-21 |
2023-04-25 |
Streck Llc |
Preservation of fetal nucleic acids in maternal plasma
|
DE102009006606A1
(de)
|
2009-01-29 |
2010-08-05 |
Philipps-Universität Marburg |
Nicht-virales Transfektionsmittel
|
WO2010096323A1
(en)
*
|
2009-02-18 |
2010-08-26 |
Streck, Inc. |
Preservation of cell-free nucleic acids
|
EP2453911A1
(en)
|
2009-04-30 |
2012-05-23 |
Genetic Immunity Kft |
Immunogenic nanomedicine composition and preparation and uses thereof
|
JP5766188B2
(ja)
|
2009-07-01 |
2015-08-19 |
プロチバ バイオセラピューティクス インコーポレイティッド |
固形腫瘍に治療剤を送達するための脂質製剤
|
US9018187B2
(en)
|
2009-07-01 |
2015-04-28 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods for the delivery of therapeutic agents
|
US8569256B2
(en)
|
2009-07-01 |
2013-10-29 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods for the delivery of therapeutic agents
|
US9856456B2
(en)
*
|
2009-10-12 |
2018-01-02 |
Thermo Fisher Scientific Baltics Uab |
Delivery agent
|
EP3252068A3
(en)
|
2009-10-12 |
2018-03-14 |
Larry J. Smith |
Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro
|
GB0917792D0
(en)
|
2009-10-12 |
2009-11-25 |
Fermentas Uab |
Delivery agent
|
WO2011057184A1
(en)
*
|
2009-11-09 |
2011-05-12 |
Streck, Inc. |
Stabilization of rna in and extracting from intact cells within a blood sample
|
US9247720B2
(en)
|
2010-03-24 |
2016-02-02 |
Institut National de la Santé et de la Recherche Médicale |
Primate model from the family cercopithecidae infected by a HBV strain of human genotype
|
EP2552460A1
(en)
|
2010-03-29 |
2013-02-06 |
Universite De Strasbourg |
Polymers for delivering molecules of interest
|
CA2802994A1
(en)
|
2010-06-17 |
2011-12-22 |
The United States Of America As Represented By The Secretary, National I Nstitutes Of Health |
Compositions and methods for treating inflammatory conditions
|
PL3135301T3
(pl)
|
2010-06-22 |
2018-11-30 |
Onxeo |
Zoptymalizowany system dostarczania in vivo z czynnikami andosomolitycznymi koniugatów kwasów nukleinowych
|
US9006417B2
(en)
|
2010-06-30 |
2015-04-14 |
Protiva Biotherapeutics, Inc. |
Non-liposomal systems for nucleic acid delivery
|
WO2012151391A2
(en)
|
2011-05-04 |
2012-11-08 |
Streck, Inc. |
Inactivated virus compositions and methods of preparing such compositions
|
US20140234373A1
(en)
|
2011-09-16 |
2014-08-21 |
Georfia Regents University |
Methods of Promoting Immune Tolerance
|
WO2013075132A1
(en)
|
2011-11-17 |
2013-05-23 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Therapeutic rna switches compositions and methods of use
|
WO2013076309A1
(en)
|
2011-11-24 |
2013-05-30 |
Genethon |
Scalable lentiviral vector production system compatible with industrial pharmaceutical applications
|
US9035039B2
(en)
|
2011-12-22 |
2015-05-19 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing SMAD4
|
CN104349794B
(zh)
*
|
2012-06-08 |
2019-01-04 |
埃泽瑞斯公司 |
信使rna的肺递送
|
CN103059295B
(zh)
*
|
2012-09-26 |
2016-01-13 |
上海交通大学 |
疏水修饰的聚乙烯亚胺及其作为蛋白质载体的用途
|
US9677073B2
(en)
|
2012-10-05 |
2017-06-13 |
Lipocalyx Gmbh |
Hydroxylated polyamine derivatives as transfection reagents
|
WO2014056590A1
(en)
|
2012-10-08 |
2014-04-17 |
Lipocalyx Gmbh |
Carboxylated polyamine derivatives as transfection reagents
|
DE102012111891A1
(de)
*
|
2012-12-06 |
2014-06-12 |
Eberhard Karls Universität Tübingen Medizinische Fakultät |
Verbesserung der Zielfindungskapazität von Stammzellen
|
US10091984B2
(en)
|
2013-07-24 |
2018-10-09 |
Streck, Inc. |
Compositions and methods for stabilizing circulating tumor cells
|
EP3068891A1
(en)
|
2013-11-13 |
2016-09-21 |
Aequus Biopharma Inc. |
Engineered glycoproteins and uses thereof
|
AU2015328012A1
(en)
|
2014-10-02 |
2017-05-11 |
Arbutus Biopharma Corporation |
Compositions and methods for silencing Hepatitis B virus gene expression
|
EP3034539A1
(en)
*
|
2014-12-19 |
2016-06-22 |
Ethris GmbH |
Compositions for introducing nucleic acid into cells
|
US11168351B2
(en)
|
2015-03-05 |
2021-11-09 |
Streck, Inc. |
Stabilization of nucleic acids in urine
|
AU2016258326A1
(en)
|
2015-05-05 |
2017-11-23 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd |
Nucleic acid-cationic polymer compositions and methods of making and using the same
|
US20180245074A1
(en)
|
2015-06-04 |
2018-08-30 |
Protiva Biotherapeutics, Inc. |
Treating hepatitis b virus infection using crispr
|
WO2017019891A2
(en)
|
2015-07-29 |
2017-02-02 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing hepatitis b virus gene expression
|
US20170145475A1
(en)
|
2015-11-20 |
2017-05-25 |
Streck, Inc. |
Single spin process for blood plasma separation and plasma composition including preservative
|
US10010627B2
(en)
|
2016-06-03 |
2018-07-03 |
International Business Machines Corporation |
Modified polycationic polymers
|
EP3491381A1
(en)
|
2016-07-29 |
2019-06-05 |
Streck, Inc. |
Suspension composition for hematology analysis control
|
CN110418650A
(zh)
|
2016-11-16 |
2019-11-05 |
免疫治疗有限公司 |
用于治疗过敏的核酸
|
US11033572B2
(en)
|
2017-01-19 |
2021-06-15 |
Universiteit Gent |
Molecular adjuvants for enhanced cytosolic delivery of active agents
|
US11203629B2
(en)
|
2017-04-22 |
2021-12-21 |
Immunomic Therapeutics, Inc. |
LAMP constructs
|
WO2018204534A1
(en)
|
2017-05-02 |
2018-11-08 |
Immunomic Therapeutics, Inc. |
Lamp (lysosomal associated membrane protein) constructs comprising cancer antigens
|
WO2019222281A1
(en)
|
2018-05-15 |
2019-11-21 |
Immunomic Therapeutics, Inc |
Improved lamp constructs comprising allergens
|
TW202043256A
(zh)
|
2019-01-10 |
2020-12-01 |
美商健生生物科技公司 |
前列腺新抗原及其用途
|
EP4045528A1
(en)
|
2019-10-18 |
2022-08-24 |
Immunomic Therapeutics, Inc. |
Improved lamp constructs comprising cancer antigens
|
CR20220220A
(es)
|
2019-11-18 |
2022-09-20 |
Janssen Biotech Inc |
Vacunas basadas en calr y jak2 mutantes y sus usos
|
WO2022009052A2
(en)
|
2020-07-06 |
2022-01-13 |
Janssen Biotech, Inc. |
Prostate neoantigens and their uses
|
WO2022009051A1
(en)
|
2020-07-06 |
2022-01-13 |
Janssen Biotech, Inc. |
A method for determining responsiveness to prostate cancer treatment
|
US20230024133A1
(en)
|
2020-07-06 |
2023-01-26 |
Janssen Biotech, Inc. |
Prostate Neoantigens And Their Uses
|
CN112237633B
(zh)
*
|
2020-10-22 |
2023-06-27 |
林君玉 |
一种pei/on复合物及其制备方法和用途
|
US11591544B2
(en)
|
2020-11-25 |
2023-02-28 |
Akagera Medicines, Inc. |
Ionizable cationic lipids
|
JP2024520797A
(ja)
|
2021-06-08 |
2024-05-24 |
タッチライト・アイピー・リミテッド |
レンチウイルスベクター
|
GB202108176D0
(en)
|
2021-06-08 |
2021-07-21 |
Touchlight Ip Ltd |
Vector
|
WO2023201201A1
(en)
|
2022-04-10 |
2023-10-19 |
Immunomic Therapeutics, Inc. |
Bicistronic lamp constructs comprising immune response enhancing genes and methods of use thereof
|